{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:13:25Z","timestamp":1793722405127,"version":"4.6.1"},"reference-count":218,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry and Physics of Lipids"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.chemphyslip.2025.105510","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T23:09:04Z","timestamp":1749251344000},"page":"105510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Solid lipid nanoparticles in the diagnosis and treatment of prostate cancer: A comprehensive review of two decades of advancements"],"prefix":"10.1016","volume":"270","author":[{"given":"Pooja","family":"Tiwary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishil","family":"Oswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6817-2261","authenticated-orcid":false,"given":"Ryan","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh","family":"Anchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardeep","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chemphyslip.2025.105510_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jconrel.2019.06.025","article-title":"Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells","volume":"307","author":"Abumanhal-Masarweh","year":"2019","journal-title":"J. Control Release"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctarc.2023.100778","article-title":"Emerging frontiers in nanomedicine targeted therapy for prostate cancer","author":"Adekiya","year":"2023","journal-title":"Cancer Treat. Res. Commun."},{"issue":"4","key":"10.1016\/j.chemphyslip.2025.105510_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2174\/1389201022666210615123211","article-title":"Recent advances in siRNA delivery systems for prostate cancer therapy","volume":"23","author":"Aghamiri","year":"2022","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"3","key":"10.1016\/j.chemphyslip.2025.105510_bib4","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/jcp.29126","article-title":"Nanoparticles and cancer therapy: perspectives for application of nanoparticles in the treatment of cancers","volume":"235","author":"Aghebati-Maleki","year":"2020","journal-title":"J. Cell Physiol."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/10837450600561182","article-title":"Influence of the formulation for solid lipid nanoparticles prepared with a membrane contactor","volume":"11","author":"Ahmed El-Harati","year":"2006","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120416","article-title":"Bioconjugated solid lipid nanoparticles (SLNs) for targeted prostate cancer therapy","volume":"599","author":"Akanda","year":"2021","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104709","article-title":"Solid lipid nanoparticles: an effective lipid-based technology for cancer treatment","author":"Akanda","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1\u20132","key":"10.1016\/j.chemphyslip.2025.105510_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2015.07.042","article-title":"Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles","volume":"493","author":"Akanda","year":"2015","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jddst.2018.01.001","article-title":"Development and evaluation of antisense shRNA-encoding plasmid loaded solid lipid nanoparticles against 5-\u03b1 reductase activity","volume":"44","author":"Akbaba","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib10","series-title":"Seminars in cancer biology","first-page":"52","article-title":"Targeting cancer cells with nanotherapeutics and nanodiagnostics: current status and future perspectives","author":"Ali","year":"2021"},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12951-023-02147-z","article-title":"Engineering siRNA therapeutics: challenges and strategies","volume":"21","author":"Ali Zaidi","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.chemphyslip.2025.105510_bib12","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/pharmaceutics15031025","article-title":"Nanotechnology in cancer diagnosis and treatment","volume":"15","author":"Alrushaid","year":"2023","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.chemphyslip.2025.105510_bib13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/ph14080707","article-title":"Emerging applications of nanotechnology in healthcare systems: grand challenges and perspectives","volume":"14","author":"Anjum","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.chemphyslip.2025.105510_bib14","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s10072-021-05234-x","article-title":"Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment","volume":"42","author":"Asefy","year":"2021","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.chemphyslip.2025.105510_bib15","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/adhm.201200338","article-title":"Optically traceable solid lipid nanoparticles loaded with siRNA and paclitaxel for synergistic chemotherapy with in situ imaging","volume":"2","author":"Bae","year":"2013","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib16","first-page":"779","article-title":"Lipid nano particulate drug delivery: an overview of the emerging trend","volume":"7","author":"Balamurugan","year":"2018","journal-title":"Pharma Innov. J."},{"issue":"9","key":"10.1016\/j.chemphyslip.2025.105510_bib17","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3390\/nano10091696","article-title":"Nanotreatment and nanodiagnosis of prostate cancer: recent updates","volume":"10","author":"Barani","year":"2020","journal-title":"Nanomaterials"},{"issue":"3","key":"10.1016\/j.chemphyslip.2025.105510_bib18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/nano9030474","article-title":"Application of solid lipid nanoparticles to improve the efficiency of anticancer drugs","volume":"9","author":"Bay\u00f3n-Cordero","year":"2019","journal-title":"Nanomaterials"},{"issue":"20","key":"10.1016\/j.chemphyslip.2025.105510_bib19","doi-asserted-by":"crossref","first-page":"16968","DOI":"10.1021\/acsomega.1c07254","article-title":"Systematic development of solid lipid nanoparticles of abiraterone acetate with improved oral bioavailability and anticancer activity for prostate carcinoma treatment","volume":"7","author":"Beg","year":"2022","journal-title":"ACS Omega"},{"issue":"11","key":"10.1016\/j.chemphyslip.2025.105510_bib20","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/ng.3967","article-title":"Patient-derived xenografts undergo mouse-specific tumor evolution","volume":"49","author":"Ben-David","year":"2017","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 update on prostate cancer epidemiology and risk factors\u2014a systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur. Urol."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib22","unstructured":"Berne B.J., Pecora R. Dynamic light scattering: with applications to chemistry, biology, and physics. Courier Corporation; 2000."},{"issue":"7","key":"10.1016\/j.chemphyslip.2025.105510_bib23","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3390\/pharmaceutics13071089","article-title":"Liquid lipids act as polymorphic modifiers of tristearin-based formulations produced by melting technologies","volume":"13","author":"Bertoni","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.chemphyslip.2025.105510_bib25","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3390\/ma15030804","article-title":"Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders","volume":"15","author":"Bhattacharya","year":"2022","journal-title":"Materials"},{"issue":"9858","key":"10.1016\/j.chemphyslip.2025.105510_bib26","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","article-title":"Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)","volume":"380","author":"Bolla","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib27","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00120-006-1204-6","article-title":"Prevention of local recurrence using adjuvant radiotherapy after radical prostatectomy: indications, results, and side effects","volume":"45","author":"Bottke","year":"2006","journal-title":"Urologe"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib28","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s11095-013-1156-7","article-title":"Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases","volume":"30","author":"Bozda\u011f Pehlivan","year":"2013","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.chemphyslip.2025.105510_bib29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib30","first-page":"398","article-title":"Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery","volume":"88","author":"Brenner","year":"2000","journal-title":"Cancer Inter. Int. J. Am. Cancer Soc."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.addr.2012.09.006","article-title":"Nanoparticles in cancer therapy and diagnosis","volume":"64","author":"Brigger","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-1-4","article-title":"Prognostic factors in prostate cancer","volume":"1","author":"Buhmeida","year":"2006","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40005-018-0394-4","article-title":"Recent formulation approaches to oral delivery of herbal medicines","volume":"49","author":"Byeon","year":"2019","journal-title":"J. Pharm. Invest."},{"issue":"105","key":"10.1016\/j.chemphyslip.2025.105510_bib34","doi-asserted-by":"crossref","DOI":"10.3791\/53102","article-title":"Solid lipid nanoparticles (SLNs) for intracellular targeting applications","author":"Calder\u00f3n-Col\u00f3n","year":"2015","journal-title":"JoVE"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib35","first-page":"1","article-title":"Solid lipid nanoparticles (SLN): prediction of toxicity, metabolism, fate and physicochemical properties","author":"Campos","year":"2020","journal-title":"Nanopharmaceuticals"},{"issue":"5","key":"10.1016\/j.chemphyslip.2025.105510_bib36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2217\/nnm-2016-0371","article-title":"Physicochemical characterization of chitosan-hyaluronan-coated solid lipid nanoparticles for the targeted delivery of paclitaxel: a proof-of-concept study in breast cancer cells","volume":"12","author":"Campos","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejmech.2012.01.001","article-title":"Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design","volume":"49","author":"Carbone","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.chemphyslip.2025.105510_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw1317","article-title":"Colorectal tumor-on-a-chip system: a 3D tool for precision onco-nanomedicine","volume":"5","author":"Carvalho","year":"2019","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.chemphyslip.2025.105510_bib39","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3390\/pharmaceutics14030506","article-title":"Magnetic solid nanoparticles and their counterparts: recent advances towards cancer theranostics","volume":"14","author":"Cerqueira","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2023.07.002","article-title":"Role of particle size in translational research of nanomedicines for successful drug delivery: discrepancies and inadequacies","author":"Chan","year":"2023","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.chemphyslip.2025.105510_bib41","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2174\/1389200219666180918111528","article-title":"Cancer nanotechnology: a new revolution for cancer diagnosis and therapy","volume":"20","author":"Chaturvedi","year":"2019","journal-title":"Curr. Drug Metab."},{"issue":"7","key":"10.1016\/j.chemphyslip.2025.105510_bib42","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1021\/acsnano.0c04006","article-title":"Nanotechnology for COVID-19: therapeutics and vaccine research","volume":"14","author":"Chauhan","year":"2020","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.chemphyslip.2025.105510_bib43","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3923\/ijp.2016.304.316","article-title":"Role of anti-apoptotic activity of antioxidants in conferring protection against prostate cancer","volume":"12","author":"Chen","year":"2016","journal-title":"Int J. Pharmacol."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40089-017-0208-0","article-title":"Nanotechnology and nanocarrier-based approaches on treatment of degenerative diseases","volume":"7","author":"Chowdhury","year":"2017","journal-title":"Int. Nano Lett."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib45","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1166\/jbn.2017.2338","article-title":"Development of pH-sensitive cationic PEGylated solid lipid nanoparticles for selective cancer-targeted therapy","volume":"13","author":"Chuang","year":"2017","journal-title":"J. Biomed. Nanotechnol."},{"issue":"11","key":"10.1016\/j.chemphyslip.2025.105510_bib46","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.3390\/molecules27113460","article-title":"A mini-review on solid lipid nanoparticles and nanostructured lipid carriers: topical delivery of phytochemicals for the treatment of acne vulgaris","volume":"27","author":"Chutoprapat","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II\u20142020 update: treatment of relapsing and metastatic prostate cancer","volume":"79","author":"Cornford","year":"2021","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.biotechadv.2013.10.011","article-title":"Clinical relevance of novel imaging technologies for sentinel lymph node identification and staging","volume":"32","author":"Cousins","year":"2014","journal-title":"Biotechnol. Adv."},{"issue":"3","key":"10.1016\/j.chemphyslip.2025.105510_bib49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0090-4295(99)80458-0","article-title":"Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient\u2019s perspective","volume":"47","author":"Crook","year":"1996","journal-title":"Urology"},{"issue":"8","key":"10.1016\/j.chemphyslip.2025.105510_bib50","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.1021\/acsnano.8b03900","article-title":"Quantifying the ligand-coated nanoparticle delivery to cancer cells in solid tumors","volume":"12","author":"Dai","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib51","article-title":"Adjuvant radiotherapy following radical prostatectomy for prostate cancer","volume":"12","author":"Daly","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"45","key":"10.1016\/j.chemphyslip.2025.105510_bib52","doi-asserted-by":"crossref","first-page":"13194","DOI":"10.1021\/acs.langmuir.1c01370","article-title":"Decapeptide modified doxorubicin loaded solid lipid nanoparticles as targeted drug delivery system against prostate cancer","volume":"37","author":"De","year":"2021","journal-title":"Langmuir"},{"issue":"8","key":"10.1016\/j.chemphyslip.2025.105510_bib53","doi-asserted-by":"crossref","first-page":"4128","DOI":"10.1021\/acs.molpharmaceut.4c00528","article-title":"Lipid-based nanocarrier by targeting with LHRH peptide: a promising approach for prostate cancer radio-imaging and therapy","volume":"21","author":"De","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib54","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12033-019-00178-2","article-title":"Nutlin3a-loaded nanoparticles show enhanced apoptotic activity on prostate cancer cells","volume":"61","author":"Debelec-Butuner","year":"2019","journal-title":"Mol. Biotechnol."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib55","doi-asserted-by":"crossref","DOI":"10.4274\/MMJ.galenos.2023.29599","article-title":"Current advances and future prospects in cancer immunotherapeutics","volume":"38","author":"Dede","year":"2023","journal-title":"Medeni. Med J."},{"issue":"4","key":"10.1016\/j.chemphyslip.2025.105510_bib56","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/wnan.1329","article-title":"Recent advances in nanotechnology for diabetes treatment","volume":"7","author":"DiSanto","year":"2015","journal-title":"Wiley Inter. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejpb.2016.08.001","article-title":"Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: current evidence from in vitro and in vivo evaluation","volume":"108","author":"Doktorovova","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"45","key":"10.1016\/j.chemphyslip.2025.105510_bib58","doi-asserted-by":"crossref","first-page":"26777","DOI":"10.1039\/D0RA03491F","article-title":"A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems","volume":"10","author":"Duan","year":"2020","journal-title":"RSC Adv."},{"issue":"20","key":"10.1016\/j.chemphyslip.2025.105510_bib59","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.3390\/molecules25204781","article-title":"Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method","volume":"25","author":"Duong","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.117263","article-title":"Nano-scale delivery systems for siRNA delivery in cancer therapy: new era of gene therapy empowered by nanotechnology","author":"Ebrahimi","year":"2023","journal-title":"Environ. Res."},{"issue":"3","key":"10.1016\/j.chemphyslip.2025.105510_bib61","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4103\/0975-1483.83765","article-title":"Formulation and evaluation of solid lipid nanoparticles of ramipril","volume":"3","author":"Ekambaram","year":"2011","journal-title":"J. Young. Pharm."},{"issue":"3","key":"10.1016\/j.chemphyslip.2025.105510_bib62","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41587-023-01783-y","article-title":"A prime editor mouse to model a broad spectrum of somatic mutations in vivo","volume":"42","author":"Ely","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.chemphyslip.2025.105510_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009063","article-title":"Challenges and opportunities in cancer immunotherapy: a society for immunotherapy of cancer (SITC) strategic vision","volume":"12","author":"Emens","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.chemphyslip.2025.105510_bib64","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.3390\/nano11113002","article-title":"Amino acids, peptides, and proteins: implications for nanotechnological applications in biosensing and drug\/gene delivery","volume":"11","author":"Er","year":"2021","journal-title":"Nanomaterials"},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0939-6411(98)00074-5","article-title":"Correlation between long-term stability of solid lipid nanoparticles (SLN\u2122) and crystallinity of the lipid phase","volume":"47","author":"Freitas","year":"1999","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib66","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-023-01849-0","article-title":"Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics","volume":"22","author":"Gajbhiye","year":"2023","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.chemphyslip.2025.105510_bib67","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/02652040802390156","article-title":"Preparation of solid lipid nanoparticles from W\/O\/W emulsions: preliminary studies on insulin encapsulation","volume":"26","author":"Gallarate","year":"2009","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib68","first-page":"1","article-title":"Cationic solid lipid nanoparticles (SLN) complexed with plasmid DNA enhance prostate cancer cells (PC-3) migration","author":"Garcia-Fossa","year":"2024","journal-title":"Nanotoxicology"},{"issue":"8","key":"10.1016\/j.chemphyslip.2025.105510_bib69","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1080\/03639045.2021.1989456","article-title":"Solid lipid nanoparticles by venturi tube: preparation, characterization and optimization by Box\u2013Behnken design","volume":"47","author":"Garc\u00eda-Salazar","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib70","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s11671-021-03628-6","article-title":"Nanoparticles for cancer therapy: current progress and challenges","volume":"16","author":"Gavas","year":"2021","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib71","article-title":"Correction: survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitors","author":"Gebrael","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"3","key":"10.1016\/j.chemphyslip.2025.105510_bib72","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/pharmaceutics15030831","article-title":"Solid lipid nanoparticles: multitasking nano-carriers for cancer treatment","volume":"15","author":"German-Cort\u00e9s","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib73","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.msec.2016.05.119","article-title":"Solid lipid nanoparticles as attractive drug vehicles: composition, properties and therapeutic strategies","volume":"68","author":"Geszke-Moritz","year":"2016","journal-title":"Mater. Sci. Eng. C."},{"issue":"6","key":"10.1016\/j.chemphyslip.2025.105510_bib74","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/1074248418778836","article-title":"Regression of atherosclerotic plaques of cholesterol-fed rabbits by combined chemotherapy with paclitaxel and methotrexate carried in lipid core nanoparticles","volume":"23","author":"Gomes","year":"2018","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib75","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: a review emphasizing on particle structure and drug release","volume":"133","author":"Gordillo-Galeano","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib76","article-title":"Integrating nanotechnology into cancer care","author":"Grodzinski","year":"2019","journal-title":"ACS Publ."},{"issue":"3","key":"10.1016\/j.chemphyslip.2025.105510_bib77","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1748-0132(07)70083-X","article-title":"Targeted nanoparticles for cancer therapy","volume":"2","author":"Gu","year":"2007","journal-title":"Nano Today"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib78","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50740","article-title":"Preclinical murine tumor models: a structural and functional perspective","volume":"9","author":"Guerin","year":"2020","journal-title":"Elife"},{"issue":"17","key":"10.1016\/j.chemphyslip.2025.105510_bib79","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.chemphyslip.2025.105510_bib80","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7326\/0003-4819-137-11-200212030-00014","article-title":"Screening for prostate cancer: an update of the evidence for the US preventive services task force","volume":"137","author":"Harris","year":"2002","journal-title":"Ann. Intern Med."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib81","article-title":"Nanotechnology in the treatment of diabetic complications: a comprehensive narrative review","volume":"2021","author":"He","year":"2021","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.med.59.061506.185523","article-title":"Nanotechnology and cancer","volume":"59","author":"Heath","year":"2008","journal-title":"Annu Rev. Med."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib83","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2013.09.046","article-title":"EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent\u2014update 2013","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib84","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jcis.2009.03.012","article-title":"Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN)","volume":"334","author":"Helgason","year":"2009","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib85","series-title":"Nanocomposite Materials for Biomedical and Energy Storage Applications","article-title":"Solid lipid nanoparticles (SLN)","author":"Hern\u00e1ndez-Esquivel","year":"2022"},{"issue":"20","key":"10.1016\/j.chemphyslip.2025.105510_bib86","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1002\/cncr.34916","article-title":"Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system","volume":"129","author":"Herr","year":"2023","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib87","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5173(02)00688-9","article-title":"Preparation and purification of cationic solid lipid nanospheres\u2014effects on particle size, physical stability and cell toxicity","volume":"254","author":"Heydenreich","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib88","series-title":"Urologic Oncology: Seminars and Original Investigations","first-page":"1","article-title":"New and emerging agents for the treatment of castration-resistant prostate cancer","author":"Higano","year":"2011"},{"issue":"10","key":"10.1016\/j.chemphyslip.2025.105510_bib89","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/jnci\/djt059","article-title":"Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer","volume":"105","author":"Hoffman","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib90","article-title":"Nanotechnology for cardiovascular diseases","volume":"3","author":"Hu","year":"2022","journal-title":"Innov"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119314","article-title":"Recent advances in theranostic polymeric nanoparticles for cancer treatment: a review","volume":"582","author":"Indoria","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib92","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.colsurfb.2014.05.041","article-title":"Adapalene loaded solid lipid nanoparticles gel: an effective approach for acne treatment","volume":"121","author":"Jain","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib93","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.colsurfb.2015.06.027","article-title":"Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin","volume":"134","author":"Jain","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib94","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/ijmr.IJMR_514_19","article-title":"Bioconjugate-loaded solid lipid nanoparticles for enhanced anticancer drug delivery to brain cancer cells: an in vitro evaluation","volume":"156","author":"Jain","year":"2022","journal-title":"Indian J. Med. Res."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib95","first-page":"327","article-title":"Targeting solid lipid nanoparticles with anisamide for docetaxel delivery to prostate cancer: preparation, optimization, and in-vitro evaluation","volume":"20","author":"Jalilian","year":"2021","journal-title":"Iran. J. Pharm. Res IJPR"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.917921","article-title":"Investigation of cellular interactions of lipid-structured nanoparticles with oral mucosal epithelial cells","volume":"9","author":"Jeitler","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib97","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-5173(00)00378-1","article-title":"Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids","volume":"199","author":"Jenning","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"18","key":"10.1016\/j.chemphyslip.2025.105510_bib98","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.7150\/ijms.49801","article-title":"Application of nanotechnology in cancer diagnosis and therapy-a mini-review","volume":"17","author":"Jin","year":"2020","journal-title":"Int. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.chemphyslip.2025.105510_bib99","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/10611860903338462","article-title":"Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system","volume":"18","author":"Kalam","year":"2010","journal-title":"J. Drug Target"},{"issue":"10","key":"10.1016\/j.chemphyslip.2025.105510_bib100","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1080\/17425247.2021.1921732","article-title":"Interdependency of influential parameters in therapeutic nanomedicine","volume":"18","author":"Kamali Shahri","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"issue":"12","key":"10.1016\/j.chemphyslip.2025.105510_bib101","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3109\/03639045.2014.909840","article-title":"Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations","volume":"40","author":"Kathe","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.chemphyslip.2025.105510_bib102","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijpharm.2014.08.008","article-title":"Formulation of solid lipid nanoparticles (SLN): the value of different alkyl polyglucoside surfactants","volume":"474","author":"Keck","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib103","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.diabres.2017.11.018","article-title":"Nanotechnology based approaches for anti-diabetic drugs delivery","volume":"136","author":"Kesharwani","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"9","key":"10.1016\/j.chemphyslip.2025.105510_bib104","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/pharmaceutics14091886","article-title":"Review on the scale-up methods for the preparation of solid lipid nanoparticles","volume":"14","author":"Khairnar","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib105","first-page":"58","article-title":"Safranal-loaded solid lipid nanoparticles: evaluation of sunscreen and moisturizing potential for topical applications","volume":"18","author":"Khameneh","year":"2015","journal-title":"Iran. J. Basic Med Sci."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib106","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2017.09.016","article-title":"Overcoming key biological barriers to cancer drug delivery and efficacy","volume":"267","author":"Kim","year":"2017","journal-title":"J. Control Release"},{"issue":"11","key":"10.1016\/j.chemphyslip.2025.105510_bib107","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1742-1241.2011.02799.x","article-title":"Characterising the castration-resistant prostate cancer population: a systematic review","volume":"65","author":"Kirby","year":"2011","journal-title":"Int. J. Clin. Pract."},{"issue":"8","key":"10.1016\/j.chemphyslip.2025.105510_bib108","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3390\/ijms20081813","article-title":"A rich array of prostate cancer molecular biomarkers: opportunities and challenges","volume":"20","author":"Kohaar","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib109","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejpb.2023.05.020","article-title":"Design, development, and in-vitro\/in-vivo evaluation of Docetaxel-loaded PEGylated solid lipid nanoparticles in prostate cancer therapy","volume":"189","author":"Korake","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.chemphyslip.2025.105510_bib110","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1039\/C4BM00427B","article-title":"Lipid-coated polymeric nanoparticles for cancer drug delivery","volume":"3","author":"Krishnamurthy","year":"2015","journal-title":"Biomater. Sci."},{"issue":"8","key":"10.1016\/j.chemphyslip.2025.105510_bib111","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1080\/07388551.2021.1993126","article-title":"Neurodegenerative disorders management: state-of-art and prospects of nano-biotechnology","volume":"42","author":"Kumar","year":"2022","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib112","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ultsonch.2017.08.018","article-title":"Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs","volume":"40","author":"Kumar","year":"2018","journal-title":"Ultrason Sonochem."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib113","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.colsurfb.2011.02.011","article-title":"Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells","volume":"85","author":"Kuo","year":"2011","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"12","key":"10.1016\/j.chemphyslip.2025.105510_bib114","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1016\/j.biomaterials.2011.01.048","article-title":"Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor","volume":"32","author":"Kuo","year":"2011","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib115","article-title":"Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability","volume":"2013","author":"Kushwaha","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib116","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3390\/ijms24021511","article-title":"Microbiome and prostate cancer: a novel target for prevention and treatment","volume":"24","author":"Kustrimovic","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib117","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41391-020-00299-9","article-title":"Management of men with metastatic castration-resistant prostate cancer following potent androgen receptor inhibition: a review of novel investigational therapies","volume":"24","author":"Labriola","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124869","article-title":"Are nanostructured lipid carriers (NLC) better than solid lipid nanoparticles (SLN) for delivering abiraterone acetate through the gastrointestinal tract?","author":"Lemasson","year":"2024","journal-title":"Int J. Pharm."},{"issue":"11","key":"10.1016\/j.chemphyslip.2025.105510_bib119","article-title":"Understanding nanomaterial\u2013liver interactions to facilitate the development of safer nanoapplications","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib120","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.2147\/IJN.S179678","article-title":"Nanotechnology, an alternative with promising prospects and advantages for the treatment of cardiovascular diseases","author":"Li","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib121","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nano.2018.05.014","article-title":"To reduce premature drug release while ensuring burst intracellular drug release of solid lipid nanoparticle-based drug delivery system with clathrin modification","volume":"15","author":"Li","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib122","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1021\/mp500656v","article-title":"Smart polymeric nanoparticles for cancer gene delivery","volume":"12","author":"Lin","year":"2015","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib123","first-page":"67","article-title":"Solid lipid nanoparticles: a review","volume":"4","author":"Lingayat","year":"2017","journal-title":"Nanosci. Nanotechnol. Res."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib124","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2147\/IJN.S115136","article-title":"Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer","author":"Liu","year":"2017","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib125","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2147\/OTT.S44144","article-title":"Androgen-deprivation therapy versus radical prostatectomy as monotherapy among clinically localized prostate cancer patients","author":"Liu","year":"2013","journal-title":"Onco Targets Ther."},{"issue":"38","key":"10.1016\/j.chemphyslip.2025.105510_bib126","doi-asserted-by":"crossref","first-page":"7878","DOI":"10.1039\/D1TB01316E","article-title":"Nanomedicine as a promising strategy for the theranostics of infectious diseases","volume":"9","author":"Liu","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"1\u20132","key":"10.1016\/j.chemphyslip.2025.105510_bib127","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijpharm.2016.12.040","article-title":"Microphase separation in solid lipid dosage forms as the cause of drug release instability","volume":"517","author":"Lopes","year":"2017","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib128","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.carbpol.2014.12.084","article-title":"Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake","volume":"122","author":"Luo","year":"2015","journal-title":"Carbohydr. Polym."},{"issue":"5","key":"10.1016\/j.chemphyslip.2025.105510_bib129","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3390\/molecules27051543","article-title":"Perspectives and prospective on solid lipid nanoparticles as drug delivery systems","volume":"27","author":"Madkhali","year":"2022","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.chemphyslip.2025.105510_bib130","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3390\/pharmaceutics15112643","article-title":"Transferrin-bearing, zein-based hybrid lipid nanoparticles for drug and gene delivery to prostate cancer cells","volume":"15","author":"Maeyouf","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.chemphyslip.2025.105510_bib131","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijpharm.2012.03.032","article-title":"Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway","volume":"430","author":"Martins","year":"2012","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib132","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.msec.2015.11.067","article-title":"Polymeric nanoparticles for targeted drug delivery system for cancer therapy","volume":"60","author":"Masood","year":"2016","journal-title":"Mater. Sci. Eng. C."},{"issue":"4","key":"10.1016\/j.chemphyslip.2025.105510_bib133","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3322\/CA.2008.0002","article-title":"Management of complications of prostate cancer treatment","volume":"58","author":"Michaelson","year":"2008","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.chemphyslip.2025.105510_bib134","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/pharmaceutics10040191","article-title":"Solid lipid nanoparticles: emerging colloidal nano drug delivery systems","volume":"10","author":"Mishra","year":"2018","journal-title":"Pharmaceutics"},{"issue":"19\u201320","key":"10.1016\/j.chemphyslip.2025.105510_bib135","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.drudis.2010.08.006","article-title":"Cancer nanotechnology: application of nanotechnology in cancer therapy","volume":"15","author":"Misra","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"23","key":"10.1016\/j.chemphyslip.2025.105510_bib136","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.chemphyslip.2025.105510_bib137","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4103\/0250-474X.57282","article-title":"Solid lipid nanoparticles: a modern formulation approach in drug delivery system","volume":"71","author":"Mukherjee","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib138","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"7","key":"10.1016\/j.chemphyslip.2025.105510_bib139","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.3390\/molecules27072202","article-title":"Optimization of the conditions of solid lipid nanoparticles (SLN) synthesis","volume":"27","author":"Musielak","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119329","article-title":"Innovative nanotechnologies for enhancing nucleic acids\/gene therapy: controlling intracellular trafficking to targeted biodistribution","volume":"218","author":"Nakamura","year":"2019","journal-title":"Biomaterials"},{"issue":"sup1","key":"10.1016\/j.chemphyslip.2025.105510_bib141","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/08958370903005769","article-title":"Low cytotoxicity of solid lipid nanoparticles in in vitro and ex vivo lung models","volume":"21","author":"Nassimi","year":"2009","journal-title":"Inhal. Toxicol."},{"issue":"3","key":"10.1016\/j.chemphyslip.2025.105510_bib142","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2174\/1381612822666161027111957","article-title":"Challenges and future prospects of nanoemulsion as a drug delivery system","volume":"23","author":"Nishitani Yukuyama","year":"2017","journal-title":"Curr. Pharm. Des."},{"issue":"8014","key":"10.1016\/j.chemphyslip.2025.105510_bib143","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/d41586-024-01428-3","article-title":"Advances in highly targeted radiation treatment for cancer have ignited interest in a once obscure field","volume":"629","author":"Nuwer","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-00781-z","article-title":"Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids","volume":"19","author":"Oner","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"3","key":"10.1016\/j.chemphyslip.2025.105510_bib145","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/13543776.2020.1720649","article-title":"Solid lipid nanoparticles: a review on recent perspectives and patents","volume":"30","author":"Paliwal","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib146","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nano.2008.08.003","article-title":"Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery","volume":"5","author":"Paliwal","year":"2009","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib147","first-page":"211","article-title":"Production of solid lipid nanoparticles-drug loading and release mechanism","volume":"2","author":"Parhi","year":"2010","journal-title":"J. Chem. Pharm. Res."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib148","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40824-018-0133-y","article-title":"New opportunities for nanoparticles in cancer immunotherapy","volume":"22","author":"Park","year":"2018","journal-title":"Biomater. Res"},{"issue":"9","key":"10.1016\/j.chemphyslip.2025.105510_bib149","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","article-title":"Prostate cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Parker","year":"2020","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib150","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/10611860701794353","article-title":"Polymeric nanoparticles for cancer therapy","volume":"16","author":"Parveen","year":"2008","journal-title":"J. Drug Target"},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib151","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10601","article-title":"A landscape of recent advances in lipid nanoparticles and their translational potential for the treatment of solid tumors","volume":"9","author":"Paun","year":"2024","journal-title":"Bioeng. Transl. Med."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib152","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1080\/10717544.2022.2086938","article-title":"Anti-lung cancer effect of paclitaxel solid lipid nanoparticles delivery system with curcumin as co-loading partner in vitro and in vivo","volume":"29","author":"Pi","year":"2022","journal-title":"Drug Deliv."},{"issue":"6","key":"10.1016\/j.chemphyslip.2025.105510_bib153","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3390\/nano10061016","article-title":"Iron oxide nanoparticles as carriers for DOX and magnetic hyperthermia after intratumoral application into breast cancer in mice: impact and future perspectives","volume":"10","author":"Piehler","year":"2020","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib154","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2007.05.051","article-title":"Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer","volume":"70","author":"Pinkawa","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib155","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1166\/jnn.2016.11669","article-title":"Application of response surface methodology for the technological improvement of solid lipid nanoparticles","volume":"16","author":"Pizzol","year":"2016","journal-title":"J. Nanosci. Nanotechnol."},{"issue":"5","key":"10.1016\/j.chemphyslip.2025.105510_bib156","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1021\/acsnano.9b01383","article-title":"Elimination pathways of nanoparticles","volume":"13","author":"Poon","year":"2019","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib157","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/cancers15020461","article-title":"Metastatic prostate cancer\u2014a review of current treatment options and promising new approaches","volume":"15","author":"Posdzich","year":"2023","journal-title":"Cancers"},{"issue":"127","key":"10.1016\/j.chemphyslip.2025.105510_bib158","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003180","article-title":"Beyond PSA: the next generation of prostate cancer biomarkers","volume":"4","author":"Prensner","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib159","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107086","article-title":"Biologics, theranostics, and personalized Medicine in drug delivery systems","author":"Puccetti","year":"2024","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib160","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5301\/uro.5000166","article-title":"Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process","volume":"83","author":"Pugliese","year":"2016","journal-title":"Urol. J."},{"issue":"4","key":"10.1016\/j.chemphyslip.2025.105510_bib161","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2174\/138920012800166526","article-title":"Absorption, disposition and pharmacokinetics of solid lipid nanoparticles","volume":"13","author":"Qi","year":"2012","journal-title":"Curr. Drug Metab."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib162","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1166\/jnn.2015.9002","article-title":"De. Factorial design and development of solid lipid nanoparticles (SLN) for gene delivery","volume":"15","author":"Radaic","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib163","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.chemphyslip.2016.05.006","article-title":"Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer","volume":"198","author":"Radhakrishnan","year":"2016","journal-title":"Chem. Phys. Lipids"},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib164","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib165","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","article-title":"Prostate cancer","volume":"7","author":"Rebello","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib166","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1007\/s13197-014-1587-0","article-title":"Crystallization modifiers in lipid systems","volume":"52","author":"Ribeiro","year":"2015","journal-title":"J. Food Sci. Technol."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib167","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.chemphyslip.2014.03.006","article-title":"Drug targeting using solid lipid nanoparticles","volume":"181","author":"Rostami","year":"2014","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib168","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jcis.2014.04.009","article-title":"Influence of co-surfactants on crystallization and stability of solid lipid nanoparticles","volume":"426","author":"Salminen","year":"2014","journal-title":"J. Colloid Interface Sci."},{"issue":"8","key":"10.1016\/j.chemphyslip.2025.105510_bib169","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/pharmaceutics13081183","article-title":"Solid lipid nanoparticles (SLNs): an advanced drug delivery system targeting brain through BBB","volume":"13","author":"Satapathy","year":"2021","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.chemphyslip.2025.105510_bib170","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41585-018-0060-7","article-title":"Landmarks in prostate cancer","volume":"15","author":"Sathianathen","year":"2018","journal-title":"Nat. Rev. Urol."},{"issue":"10","key":"10.1016\/j.chemphyslip.2025.105510_bib171","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"1\u20132","key":"10.1016\/j.chemphyslip.2025.105510_bib172","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejpb.2005.03.006","article-title":"Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier","volume":"61","author":"Schubert","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib173","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0022-5347(05)64652-6","article-title":"Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program","volume":"168","author":"See","year":"2002","journal-title":"J. Urol."},{"issue":"17","key":"10.1016\/j.chemphyslip.2025.105510_bib174","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.chemphyslip.2025.105510_bib175","first-page":"563","article-title":"Development, evaluation, pharmacokinetic and biodistribution estimation of resveratrol-loaded solid lipid nanoparticles for prostate cancer targeting","volume":"39","author":"Sharma","year":"2022","journal-title":"J. Micro"},{"issue":"5","key":"10.1016\/j.chemphyslip.2025.105510_bib176","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/adhm.201200006","article-title":"A novel solid lipid nanoparticle formulation for active targeting to tumor \u03b1v\u03b23 integrin receptors reveals cyclic RGD as a double-edged sword","volume":"1","author":"Shuhendler","year":"2012","journal-title":"Adv. Health Mater."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib177","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel Mph","year":"2023","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib178","first-page":"62","article-title":"Trends of nanotechnology in type 2 diabetes mellitus treatment","volume":"16","author":"Simos","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.chemphyslip.2025.105510_bib179","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.3390\/ijms24076199","article-title":"Solid lipid nanoparticles: applications and prospects in cancer treatment","volume":"24","author":"Sivadasan","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib180","first-page":"62","article-title":"Lipid nanoparticles (SLN)-an alternative colloidal carrier system for controlled drug delivery","volume":"41","author":"Solid","year":"1995","journal-title":"Eur. J. Biopharm."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib181","doi-asserted-by":"crossref","first-page":"301","DOI":"10.34172\/apb.2023.033","article-title":"Preparation and characterization of magnetic solid lipid nanoparticles as a targeted drug delivery system for doxorubicin","volume":"13","author":"Soltani","year":"2023","journal-title":"Adv. Pharm. Bull."},{"issue":"9","key":"10.1016\/j.chemphyslip.2025.105510_bib182","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0959-8049(00)00084-8","article-title":"Fatigue in patients with prostate cancer receiving hormone therapy","volume":"36","author":"Stone","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib183","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1002\/anie.201403036","article-title":"Engineered nanoparticles for drug delivery in cancer therapy","volume":"53","author":"Sun","year":"2014","journal-title":"Angew. Chem. Int Ed."},{"issue":"4","key":"10.1016\/j.chemphyslip.2025.105510_bib184","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1158\/1535-7163.MCT-07-0442","article-title":"Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53","volume":"7","author":"Supiot","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"1\u20132","key":"10.1016\/j.chemphyslip.2025.105510_bib185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijpharm.2015.03.065","article-title":"Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting","volume":"486","author":"Swami","year":"2015","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib186","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.colsurfb.2018.08.067","article-title":"Physicochemical characterization of solid lipid nanoparticles comprised of glycerol monostearate and bile salts","volume":"172","author":"Talele","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101019","article-title":"Insights from nanotechnology in COVID-19 treatment","volume":"36","author":"Tang","year":"2021","journal-title":"Nano Today"},{"issue":"19","key":"10.1016\/j.chemphyslip.2025.105510_bib188","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1001\/jama.296.19.2329","article-title":"Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial","volume":"296","author":"Thompson","year":"2006","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib189","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12951-022-01552-0","article-title":"Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system","volume":"20","author":"Tian","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-018-1229-3","article-title":"Drug-lipid-surfactant miscibility for the development of solid lipid nanoparticles","volume":"20","author":"Trivino","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib191","unstructured":"Tscharnuter W. Photon correlation spectroscopy in particle sizing. Encycl Anal Chem Appl theory Instrum. 2006;"},{"issue":"4","key":"10.1016\/j.chemphyslip.2025.105510_bib192","first-page":"331","article-title":"Influence of surfactants on the physical stability of solid lipid nanoparticle (SLN) formulations. Die pharm","volume":"59","author":"\u00dcner","year":"2004","journal-title":"Int J. Pharm. Sci."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122014","article-title":"Design of nanostructured lipid carriers and solid lipid nanoparticles for enhanced cellular uptake","volume":"624","author":"Veider","year":"2022","journal-title":"Int J. Pharm."},{"issue":"6","key":"10.1016\/j.chemphyslip.2025.105510_bib194","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.3390\/pharmaceutics15061593","article-title":"Solid lipid nanoparticles vs. Nanostructured lipid carriers: a comparative review","volume":"15","author":"Viegas","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.colsurfb.2010.12.024","article-title":"The size of solid lipid nanoparticles: an interpretation from experimental design","volume":"84","author":"Vitorino","year":"2011","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.chemphyslip.2025.105510_bib196","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1208\/pt0804083","article-title":"Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles","volume":"8","author":"Vivek","year":"2007","journal-title":"Aaps Pharmscitech"},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib197","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-024-01889-y","article-title":"Current advance of nanotechnology in diagnosis and treatment for malignant tumors","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib198","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.biopha.2016.12.041","article-title":"Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer","volume":"86","author":"Wang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2021.102387","article-title":"Nanotechnology applications for cardiovascular disease treatment: current and future perspectives","volume":"34","author":"Wang","year":"2021","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3322\/CA.2007.0003","article-title":"Application of nanotechnology in cancer therapy and imaging","volume":"58","author":"Wang","year":"2008","journal-title":"CA Cancer J. Clin."},{"issue":"22","key":"10.1016\/j.chemphyslip.2025.105510_bib201","doi-asserted-by":"crossref","first-page":"14257","DOI":"10.3390\/ijms232214257","article-title":"Complexities of prostate cancer","volume":"23","author":"Wasim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib202","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s13346-023-01398-5","article-title":"Microfluidic encapsulation of enzymes and steroids within solid lipid nanoparticles","volume":"14","author":"Weaver","year":"2024","journal-title":"Drug Deliv. Transl. Res"},{"issue":"6","key":"10.1016\/j.chemphyslip.2025.105510_bib203","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1021\/acsnano.0c03697","article-title":"Toward nanotechnology-enabled approaches against the COVID-19 pandemic","volume":"14","author":"Weiss","year":"2020","journal-title":"ACS Nano"},{"issue":"2\u20133","key":"10.1016\/j.chemphyslip.2025.105510_bib204","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0168-3659(97)00046-1","article-title":"Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential","volume":"48","author":"Westesen","year":"1997","journal-title":"J. Control Release"},{"issue":"18","key":"10.1016\/j.chemphyslip.2025.105510_bib205","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1200\/JCO.2008.18.9563","article-title":"Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02\/AUO AP 09\/95","volume":"27","author":"Wiegel","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.chemphyslip.2025.105510_bib206","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.addr.2007.04.008","article-title":"Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles","volume":"59","author":"Wong","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chemphyslip.2025.105510_bib207","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.2147\/IJN.S182621","article-title":"Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells","author":"Xu","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib208","doi-asserted-by":"crossref","DOI":"10.1002\/anbr.202100109","article-title":"Lipid nanoparticles for drug delivery","volume":"2","author":"Xu","year":"2022","journal-title":"Adv. NanoBiomed Res."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib209","first-page":"8","article-title":"Solid lipid nanoparticles-a review","volume":"5","author":"Yadav","year":"2013","journal-title":"Int. J. Appl. Pharm."},{"issue":"24","key":"10.1016\/j.chemphyslip.2025.105510_bib210","doi-asserted-by":"crossref","first-page":"13537","DOI":"10.3390\/ijms222413537","article-title":"On the road to accurate protein biomarkers in prostate cancer diagnosis and prognosis: current status and future advances","volume":"22","author":"Yan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib211","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcis.2012.02.024","article-title":"Experimental investigation and population balance equation modeling of solid lipid nanoparticle aggregation dynamics","volume":"374","author":"Yang","year":"2012","journal-title":"J. Colloid Interface Sci."},{"issue":"12","key":"10.1016\/j.chemphyslip.2025.105510_bib212","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3390\/pharmaceutics12121184","article-title":"Potential and applications of nanocarriers for efficient delivery of biopharmaceuticals","volume":"12","author":"Zeb","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.chemphyslip.2025.105510_bib213","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1568026619666190125145836","article-title":"Nanoparticle therapy for prostate cancer: overview and perspectives","volume":"19","author":"Zhang","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"issue":"4","key":"10.1016\/j.chemphyslip.2025.105510_bib214","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3390\/molecules23040826","article-title":"Nanotechnology for cancer therapy based on chemotherapy","volume":"23","author":"Zhao","year":"2018","journal-title":"Molecules"},{"issue":"23","key":"10.1016\/j.chemphyslip.2025.105510_bib215","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1021\/la501141m","article-title":"Mixture of nonionic\/ionic surfactants for the formulation of nanostructured lipid carriers: effects on physical properties","volume":"30","author":"Zhao","year":"2014","journal-title":"Langmuir"},{"issue":"6","key":"10.1016\/j.chemphyslip.2025.105510_bib216","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41565-023-01323-4","article-title":"Machine-learning-assisted single-vessel analysis of nanoparticle permeability in tumour vasculatures","volume":"18","author":"Zhu","year":"2023","journal-title":"Nat. Nanotechnol."},{"issue":"7","key":"10.1016\/j.chemphyslip.2025.105510_bib217","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.clinthera.2016.03.026","article-title":"Current challenges in cancer treatment","volume":"38","author":"Zugazagoitia","year":"2016","journal-title":"Clin. Ther."},{"issue":"2","key":"10.1016\/j.chemphyslip.2025.105510_bib218","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0939-6411(97)00150-1","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013drug release and release mechanism","volume":"45","author":"zur M\u00fchlen","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Chemistry and Physics of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308425000465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308425000465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:02:52Z","timestamp":1751382172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009308425000465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":218,"alternative-id":["S0009308425000465"],"URL":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2025.105510","relation":{},"ISSN":["0009-3084"],"issn-type":[{"value":"0009-3084","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solid lipid nanoparticles in the diagnosis and treatment of prostate cancer: A comprehensive review of two decades of advancements","name":"articletitle","label":"Article Title"},{"value":"Chemistry and Physics of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2025.105510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105510"}}